TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression,

Michale Bouskila1, Noor Esoof, Laurie Gay

  • 1MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, Scotland, U.K.

Insights

Mutations in tau tubulin kinase 2 (TTBK2) cause spinocerebellar ataxia type 11 (SCA11). This study reveals how these mutations affect TTBK2 expression, activity, and localization, providing insights into the disease mechanism.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Mutations in tau tubulin kinase 2 (TTBK2) are linked to spinocerebellar ataxia type 11 (SCA11), an inherited movement disorder.
  • Understanding the intrinsic properties of TTBK2 and the functional consequences of SCA11-associated mutations is crucial for disease mechanism elucidation.

Purpose of the Study:

  • To characterize the substrate specificity and catalytic activity of TTBK2.
  • To investigate the impact of SCA11-causing mutations on TTBK2 protein expression, kinase activity, and cellular localization.
  • To develop a preclinical model for studying SCA11.

Main Methods:

  • Biochemical assays to determine TTBK2 substrate specificity and quantify kinase activity using a novel peptide substrate (TTBKtide).
  • Computational modeling and site-directed mutagenesis to identify functional domains within TTBK2.
  • Generation and analysis of a knockin mouse model carrying an SCA11-associated mutation.
  • Assessment of TTBK2 protein expression, kinase activity, and subcellular localization in cellular and animal models.

Main Results:

  • TTBK2 exhibits a unique preference for phosphotyrosine at the +2 position, and a specific peptide substrate (TTBKtide) was developed.
  • A phosphate-priming groove within the TTBK2 kinase domain was identified through modeling and mutagenesis.
  • SCA11 mutations were found to increase TTBK2 protein expression, reduce kinase activity, and enhance nuclear localization.
  • The SCA11-mutation-carrying knockin mouse model demonstrated inhibited endogenous TTBK2 kinase activity.
  • Homozygosity for the SCA11 mutation resulted in embryonic lethality around day 10 of gestation.

Conclusions:

  • This study provides novel insights into the biochemical properties of TTBK2 and the molecular mechanisms underlying SCA11.
  • SCA11-causing mutations disrupt TTBK2 function by altering protein expression, catalytic activity, and subcellular localization.
  • The generated knockin mouse model serves as a valuable tool for future research into TTBK2 function and SCA11 pathogenesis.